Past, Present and Future of Genetic Cancer Risk Assessment
Genetic testing can help estimate a person’s chance of developing cancer in his/her lifetime based on changes and mutations in his/her genetic pedigree. It is important for physicians to identify appropriate patients to refer for a genetic cancer risk assessment (GCRA). This course summarizes the benefits and limitations of surveillance and risk management options for cancer predisposition syndrome.
RETURN TO MAIN PAGE: Breast Cancer for the Non-Oncologist: Supporting Your Patients Through Diagnosis and Treatment
Original Release Date: August 2017
Review Date: December 2021
Target Audience
General Surgeons, Family Medicine Physicians, Internal Medicine Physicians, Oncologists, Medical Oncologists, Hospitalists, Nurse Practitioners, Physician Assistants and all other interested healthcare professionals.
Learning Objectives
- Identify appropriate patients to refer for a genetic cancer risk assessment (GCRA).
- Explain the GCRA process and recognize the changing landscape of genetic testing – syndrome-driven versus multigene panels.
- Summarize the benefits and limitations of surveillance and risk management options for cancer predisposition syndrome.
Arelis E. Martir-Negron, M.D., FACMG
Medical Geneticist
Miami Cancer Institute
Miami, Florida
Arelis E. Martir-Negron, M.D., FACMG, faculty for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Rogelio Ribas, M.D., conference director for this educational activity, has no relevant financial relationship with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |